OAM
EXAS

Ostrum Asset Management’s Exact Sciences EXAS Stock Holding History

Ostrum Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,984
Closed -$172K – 595
2025
Q1 		$172K Sell
3,984
-2,314
-37% -$117K 0.01% 512
2024
Q4 		$354K Buy
6,298
+2,039
+48% +$127K 0.03% 439
2024
Q3 		$290K Sell
4,259
-2,212
-34% -$125K 0.02% 456
2024
Q2 		$273K Buy
6,471
+1,163
+22% +$64K 0.02% 465
2024
Q1 		$367K Buy
5,308
+1,360
+34% +$86K 0.03% 477
2023
Q4 		$292K Sell
3,948
-3,833
-49% -$251K 0.03% 482
2023
Q3 		$531K Buy
7,781
+574
+8% +$48.7K 0.05% 431
2023
Q2 		$677K Sell
7,207
-680
-9% -$53K 0.06% 387
2023
Q1 		$535K Buy
+7,887
New +$507K 0.05% 415

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Ostrum Asset Management's EXAS Position: Q2 2025 in Review

Ostrum Asset Management sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 3,984 shares — an estimated $172K sold.

Ostrum Asset Management first reported a position in EXAS in Q1 2023 and held it in 9 quarters. The position peaked at $677K in Q2 2023. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Ostrum Asset Management reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Ostrum Asset Management sold 3,984 Exact Sciences shares in Q2 2025, an estimated $172K.
  • Ostrum Asset Management first reported a position in Exact Sciences in Q1 2023 and held it in 9 quarters.
  • Ostrum Asset Management's Exact Sciences position peaked at $677K in Q2 2023.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Ostrum Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.